Cargando…

Evaluation of circulating tumor DNA as a biomarker for gynecological tumors

Detalles Bibliográficos
Autores principales:	Liu, Kang-Sheng, Tong, Hua, Li, Tai-Ping, Chen, Ya-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722560/ https://www.ncbi.nlm.nih.gov/pubmed/33009020 http://dx.doi.org/10.1097/CM9.0000000000001140

Ejemplares similares

Electrochemical Biosensors for Circulating Tumor DNA Detection
por: Wang, Ke, et al.
Publicado: (2022)

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
por: Pereira, Elena, et al.
Publicado: (2015)

ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors
por: Abbosh, Christopher, et al.
Publicado: (2021)

Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection
por: Pantel, Klaus
Publicado: (2016)

Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients
por: Charo, Lindsey M., et al.
Publicado: (2020)

Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma
por: von Felden, Johann, et al.
Publicado: (2018)

Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
por: Agashe, Ruchi, et al.
Publicado: (2020)

Clinical significance of intratumor heterogeneity for gynecological carcinoma
por: Yang, Ying-Chao, et al.
Publicado: (2015)

Circulating tumor DNA as a therapy response marker in metastatic colorectal cancer
por: Ma, Xiaoju Max, et al.
Publicado: (2022)

Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges
por: Herrero, Carolina, et al.
Publicado: (2020)

Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

MicroRNAs and Their Targetomes in Tumor-Immune Communication
por: Cho, Sunglim, et al.
Publicado: (2020)

A Curriculum Using Simulation Models to Teach Gynecology and Obstetrics to Trainees
por: Ren, He-Ya, et al.
Publicado: (2017)

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC
por: Smith, Jarrod T., et al.
Publicado: (2020)

Current advances in circulating inflammatory biomarkers in atherosclerosis and related cardio-cerebrovascular diseases
por: Lv, Jun-Xuan, et al.
Publicado: (2017)

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis
por: Uesato, Yasunori, et al.
Publicado: (2020)

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma
por: Garcés, Juan-José, et al.
Publicado: (2022)

Detection and Characterization of Circulating Tumor Cells Using Imaging Flow Cytometry—A Perspective Study
por: Muchlińska, Anna, et al.
Publicado: (2022)

Gynecological cancers: an alternative approach to healing
por: Saso, Srdjan, et al.
Publicado: (2017)

Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review
por: Räihä, Meri R., et al.
Publicado: (2018)

Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions
por: Bagnoli, Marina, et al.
Publicado: (2019)

Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
por: Lu, Jun-Liang, et al.
Publicado: (2016)

Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer
por: Hai, Luo, et al.
Publicado: (2022)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy
por: Chen, Tai-Heng
Publicado: (2020)

Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
por: Yang, Fang, et al.
Publicado: (2021)

Treatment and Prevention Strategies for Patients with Gynecological Malignancies During the COVID-19 Pandemic
por: Yang, Jiang, et al.
Publicado: (2020)

Quantitative image analysis for evaluation of tumor response in clinical oncology
por: Cai, Wen-Li, et al.
Publicado: (2018)

Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer
por: Zhou, Hekai, et al.
Publicado: (2023)

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
por: Wen, Xiaosha, et al.
Publicado: (2022)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
por: Diefenbach, Russell J, et al.
Publicado: (2020)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

Circulating MicroRNAs in gynecological malignancies: from detection to prediction
por: Zhao, Ya-Nan, et al.
Publicado: (2014)

Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer
por: Miller, Philip C., et al.
Publicado: (2019)

A dual biomarker detection platform for quantitating circulating tumor DNA (ctDNA)
por: Cai, Chunyan, et al.
Publicado: (2018)

Expression of circular RNAs in gynecological tumors: A systematic review
por: Liu, Kangsheng, et al.
Publicado: (2019)

Detection of Circulating Tumor Cell-Related Markers in Gynecologic Cancer Using Microfluidic Devices: A Pilot Study
por: Law, Kim-Seng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vbib9lvshjbf928avqp7khvbk3